ATLANTA, GA AND ROCHESTER, NY – Alimera Sciences, a privately-held company headquartered in Atlanta, GA and Bausch & Lomb (NYSE:BOL) today announced that Bausch & Lomb has purchased Alimera’s OTC allergy franchise, including Alaway (ketotifen fumarate ophthalmic solution 0.025%), which was recently approved by the U.S. Food and Drug Administration.

ATLANTA (December 5, 2006) — Alimera Sciences Inc., an ophthalmic pharmaceutical company founded just three years ago, today announced that the U. S. Food and Drug Administration (FDA) has approved its ophthalmic solution Rx–to-OTC-switch new drug application (NDA) for Alaway™ (ketotifen fumarate ophthalmic solution 0.025%). Alaway™, a multiple action eye anti-allergic, is Alimera’s first NDA submission and the first to win approval. Indicated for the temporary relief of itchy eyes, Alaway™ will be marketed over-the-counter with the prescription strength active ingredient found in a prescription allergy eye drop.

ATLANTA (November 27, 2006) — Alimera Sciences Inc., an ophthalmic pharmaceutical company, announced today that it has completed the second tranche of its Series B financing, receiving $15.9 million in additional venture capital. This represents the culmination of the Company’s Series B financing of $31.8 million secured in November 2005, at which time Alimera received an initial $15.9 million in proceeds.

ATLANTA (November 27, 2006) — Alimera Sciences Inc., an ophthalmic pharmaceutical company, announced today that it has completed the second tranche of its Series B financing, receiving $15.9 million in additional venture capital. This represents the culmination of the Company’s Series B financing of $31.8 million secured in November 2005, at which time Alimera received an initial $15.9 million in proceeds.

ATLANTA, GA and RICHMOND, TX (July 17, 2006) – Alimera Sciences Inc., an emerging ophthalmic pharmaceutical company, and CYNACON / OCuSOFT, a broad based supplier of ophthalmic pharmaceuticals and supplies, today announced an agreement for Alimera Sciences sales representatives to begin detailing and sampling the OCuSOFT® Lid Scrub family of eyelid cleansers to existing ophthalmic and optometric customers.